Global Soliris Drug Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Soliris Drug
- 1.1 Definition of Soliris Drug
- 1.2 Soliris Drug Segment by Type
- 1.2.1 Global Soliris Drug Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Plasma Exchange
- 1.2.3 Plasma Infusion
- 1.3 Soliris Drug Segment by Applications
- 1.3.1 Global Soliris Drug Consumption Comparison by Applications (2014-2025)
- 1.3.2 PNH
- 1.3.3 aHUS
- 1.3.4 Other
- 1.4 Global Soliris Drug Overall Market
- 1.4.1 Global Soliris Drug Revenue (2014-2025)
- 1.4.2 Global Soliris Drug Production (2014-2025)
- 1.4.3 North America Soliris Drug Status and Prospect (2014-2025)
- 1.4.4 Europe Soliris Drug Status and Prospect (2014-2025)
- 1.4.5 China Soliris Drug Status and Prospect (2014-2025)
- 1.4.6 Japan Soliris Drug Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Soliris Drug Status and Prospect (2014-2025)
- 1.4.8 India Soliris Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Soliris Drug
- 2.3 Manufacturing Process Analysis of Soliris Drug
- 2.4 Industry Chain Structure of Soliris Drug
3 Development and Manufacturing Plants Analysis of Soliris Drug
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Soliris Drug Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Soliris Drug
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Soliris Drug Production and Capacity Analysis
- 4.2 Soliris Drug Revenue Analysis
- 4.3 Soliris Drug Price Analysis
- 4.4 Market Concentration Degree
5 Soliris Drug Regional Market Analysis
- 5.1 Soliris Drug Production by Regions
- 5.1.1 Global Soliris Drug Production by Regions
- 5.1.2 Global Soliris Drug Revenue by Regions
- 5.2 Soliris Drug Consumption by Regions
- 5.3 North America Soliris Drug Market Analysis
- 5.3.1 North America Soliris Drug Production
- 5.3.2 North America Soliris Drug Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Soliris Drug Import and Export
- 5.4 Europe Soliris Drug Market Analysis
- 5.4.1 Europe Soliris Drug Production
- 5.4.2 Europe Soliris Drug Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Soliris Drug Import and Export
- 5.5 China Soliris Drug Market Analysis
- 5.5.1 China Soliris Drug Production
- 5.5.2 China Soliris Drug Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Soliris Drug Import and Export
- 5.6 Japan Soliris Drug Market Analysis
- 5.6.1 Japan Soliris Drug Production
- 5.6.2 Japan Soliris Drug Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Soliris Drug Import and Export
- 5.7 Southeast Asia Soliris Drug Market Analysis
- 5.7.1 Southeast Asia Soliris Drug Production
- 5.7.2 Southeast Asia Soliris Drug Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Soliris Drug Import and Export
- 5.8 India Soliris Drug Market Analysis
- 5.8.1 India Soliris Drug Production
- 5.8.2 India Soliris Drug Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Soliris Drug Import and Export
6 Soliris Drug Segment Market Analysis (by Type)
- 6.1 Global Soliris Drug Production by Type
- 6.2 Global Soliris Drug Revenue by Type
- 6.3 Soliris Drug Price by Type
7 Soliris Drug Segment Market Analysis (by Application)
- 7.1 Global Soliris Drug Consumption by Application
- 7.2 Global Soliris Drug Consumption Market Share by Application (2014-2019)
8 Soliris Drug Major Manufacturers Analysis
- 8.1 Alexion
- 8.1.1 Alexion Soliris Drug Production Sites and Area Served
- 8.1.2 Alexion Product Introduction, Application and Specification
- 8.1.3 Alexion Soliris Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
9 Development Trend of Analysis of Soliris Drug Market
- 9.1 Global Soliris Drug Market Trend Analysis
- 9.1.1 Global Soliris Drug Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Soliris Drug Regional Market Trend
- 9.2.1 North America Soliris Drug Forecast 2019-2025
- 9.2.2 Europe Soliris Drug Forecast 2019-2025
- 9.2.3 China Soliris Drug Forecast 2019-2025
- 9.2.4 Japan Soliris Drug Forecast 2019-2025
- 9.2.5 Southeast Asia Soliris Drug Forecast 2019-2025
- 9.2.6 India Soliris Drug Forecast 2019-2025
- 9.3 Soliris Drug Market Trend (Product Type)
- 9.4 Soliris Drug Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Soliris Drug Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
The global Soliris Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Soliris Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Soliris Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Soliris Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Soliris Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Alexion
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Other